Aspen Global - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAspen Global

Aspen Global(ASPU)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Cyclessa	Desogestrel, Ethinyl estradiol	2000-12-20	2023-2039	Prostatic neoplasms , Breast neoplasms , Menorrhagia , Uterine hemorrhage , Contraception , Primary ovarian insufficiency , Amenorrhea , Hot flashes , Hypogonadism , Premature menopause , Acne vulgaris , Endometriosis , Endometrial hyperplasia , Menstruation disturbances , Female infertility , Folic acid deficiency , Megaloblastic anemia
Glycopyrrolate	Glycopyrrolate	2022-11-29	2024-2038	Respiratory tract diseases , Peptic ulcer , Drug-induced abnormalities , Asthma , Bronchial spasm , Inflammatory bowel diseases , Allergic rhinitis perennial , Chronic bronchitis , Pulmonary emphysema , Urinary retention , Myasthenia gravis , Urinary bladder diseases
Hexadrol	Dexamethasone	1982-01-01	2023-2039	Leukemia , Septic shock , Ulcerative colitis , Ankylosing spondylitis , Macular edema , Vomiting , Nausea , Uveitis , Sarcoidosis , Thrombocytopenic purpura idiopathic , Pulmonary tuberculosis , Mycosis fungoides , Systemic lupus erythematosus , Rheumatic diseases , Bursitis , Keratitis , Allergic rhinitis perennial , Thyroiditis , Iritis , Hypercalcemia , Brain edema , Pemphigus , Addison disease , Collagen diseases , Dermatitis herpetiformis , Wounds and injuries , Gastrointestinal diseases , Bacterial infections , Pseudomonas infections , Bacterial skin diseases , Skin diseases , Escherichia coli infections , Soft tissue infections , Bacterial eye infections , Urinary bladder diseases , Hepatic encephalopathy , Bacterial meningitis , Bacteremia , Klebsiella infections , Otitis externa , Haemophilus infections , Respiratory tract infections , Urinary tract infections , Intraabdominal infections , Infectious skin diseases , Staphylococcal infections , Central nervous system infections , Infectious bone diseases , Pain , Ventricular tachycardia , Cardiac arrhythmias , Burns , Esophageal diseases , Ventricular fibrillation , Ventricular premature complexes , Mouth diseases , Paroxysmal tachycardia , Neutropenia , Prostatitis , Fever , Sinusitis , Typhoid fever , Diarrhea , Gonorrhea , Osteomyelitis , Campylobacter infections , Bacterial conjunctivitis , Infectious arthritis , Pyelonephritis , Proteus infections , Anthrax , Protozoan infections , Cystitis , Dysentery , Bacteroides infections
Hydroxyprogesterone caproate	Hydroxyprogesterone caproate	2015-08-24		—
Orgaran	Danaparoid	1996-12-24		Venous thrombosis, Pulmonary embolism, Thromboembolism, Thrombocytopenia
Liquaemin	Heparin	1982-01-01	2024-2042	Myocardial infarction, Pulmonary embolism, Postoperative complications, Thromboembolism, Cerebral infarction, Coronary thrombosis, Unstable angina, Thrombophlebitis, Migraine disorders, Pain, Ventricular tachycardia, Orthostatic hypotension, Cardiac arrhythmias, Cluster headache, Postpartum hemorrhage, Xerostomia, Burns, Esophageal diseases, Ventricular fibrillation, Ventricular premature complexes, Mouth diseases, Paroxysmal tachycardia

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

injection site reaction

thrombocytopenia

injection site reaction

Danaparoid sodium

thrombocytopenia

Nadroparin calcium

injection site reaction

thrombocytopenia

Sodium chloride

injection site reaction

,

atrophic vaginitis

thrombocytopenia

thrombocytopenia

thrombocytopenia

thrombocytopenia

thrombocytopenia

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use